Skip to main content
Back to Korea Investment Partners

Korea Investment Partners's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by Korea Investment Partners. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$52.0M

Therapeutics Portfolio Companies (3)

Export
BiotechnologyMedicalOncologyTherapeuticsWellness

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Cambridge, United States
October 2025
$47.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Plymouth Meeting, United States
September 2023
$5.0M
Series A

Founder Contacts

19,000+ verified contacts

AppsHealth CareInformation TechnologyTherapeutics

S-Alpha Therapeutics engages in the research and development of health apps and digital therapeutics.

Seocho, South Korea
November 2025
Series C

Founder Contacts

19,000+ verified contacts

Explore Korea Investment Partners's Full Portfolio

View all companies funded by Korea Investment Partners across every industry and funding stage.

View Full Korea Investment Partners Portfolio